Discovery of adamantane ethers as inhibitors of 11β-HSD-1: Synthesis and biological evaluation
Authors:
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (3) , 750-755
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Benzothiazole derivatives as novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1Molecular and Cellular Endocrinology, 2006
- Definition of Metabolic SyndromeCirculation, 2004
- Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1Journal of Medicinal Chemistry, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Adipocyte metabolism and the metabolic syndromeDiabetes, Obesity and Metabolism, 2001
- Minireview: 11 -Hydroxysteroid Dehydrogenase Type 1-- A Tissue-Specific Amplifier of Glucocorticoid ActionEndocrinology, 2001
- Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairmentsProceedings of the National Academy of Sciences, 2001
- Cortisol metabolism and the role of 11β-hydroxysteroid dehydrogenaseBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- Phenotypic analysis of mice bearing targeted deletions of 11β-hydroxysteroid dehydrogenases 1 and 2 genesMolecular and Cellular Endocrinology, 2001
- 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stressProceedings of the National Academy of Sciences, 1997